Similarly, flow cytometry analysis of CD3−CD56+ and/or CD16+ cells in the peripheral blood of DLBCL and (follicular lymphoma) FL patients demonstrated that both DLBCL and FL patients had low NKC, which was correlated with a reduction in progression-free survival (PFS) and OS [90]. The gene discussed is FCGR3A; the disease is diffuse large B-cell lymphoma.